Laddar...
Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy
PURPOSE: To evaluate costs of panretinal photocoagulation (PRP) vs. intravitreal ranibizumab (IVR) for proliferative diabetic retinopathy (PDR). DESIGN: A Markov-style model of cost-effectiveness and cost utility. PARTICIPANTS: There were no participants. METHODS: Based on results from Diabetic Reti...
Sparad:
| I publikationen: | Ophthalmology |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995116/ https://ncbi.nlm.nih.gov/pubmed/27425822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.05.037 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|